Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium Breve PRL2020 for Antibiotic-Associated GI Symptoms
NCT05840588Completed
- Sponsor
- Liaquat University of Medical and Health Sciences
- Start
- Nov 2023
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Liaquat University of Medical and Health Sciences. Primary endpoints: Incidence of antibiotic-associated diarrhea and Incidence of gastrointestinal symptoms other than diarrhea. Started Nov 2023; status: completed.
Beyond the preview
Go deeper on NCT05840588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05840588.